Cerus (CERS) Current Assets (2010 - 2026)
Cerus (CERS) reported Current Assets of $175.3 million for Q1 2026, up 8.56% on a YoY basis from $161.5 million in Q1 2025, and up 0.55% sequentially from $174.4 million in Q4 2025.
Cerus (CERS) Current Assets (2010 - 2026) Analysis & Trends
Cerus (CERS) has 17 years of Current Assets data on file, last reported at $175.3 million in Q1 2026.
- For the quarter ending Q1 2026, Current Assets rose 8.56% year-over-year to $175.3 million; the trailing twelve-month figure through Mar 2026 stood at $175.3 million (up 8.56% YoY), and the FY2025 full-year result was $174.4 million, up 14.71% from the prior year.
- Current Assets rose to $175.3 million in Q1 2026, from $174.4 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $175.3 million in Q1 2026 to a low of $135.0 million in Q2 2024.
- A 5-year average of $158.4 million and a median of $162.2 million in 2023 frame the typical range for Current Assets.
- Across the five-year window, Current Assets slipped 15.11% in 2023 and gained 24.81% in 2025, its largest moves.
- Tracing CERS's Current Assets over 5 years: stood at $170.1 million in 2022, then slipped by 15.11% to $144.4 million in 2023, then gained by 5.25% to $152.0 million in 2024, then advanced by 14.71% to $174.4 million in 2025, then increased by 0.55% to $175.3 million in 2026.
- Business Quant data shows CERS's Current Assets at $175.3 million in Q1 2026, $174.4 million in Q4 2025, and $167.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.35 Bn | 180.06 Bn | 6.27 Bn | 25.51 Bn |
| 2 | Stryker | 132.18 Bn | 129.31 Bn | 3.81 Bn | 13.34 Bn |
| 3 | Medtronic | 111.47 Bn | 102.25 Bn | 6.41 Bn | 24.79 Bn |
| 4 | Boston Scientific | 68.97 Bn | 67.51 Bn | 3.61 Bn | 8.68 Bn |
| 5 | Edwards Lifesciences | 48.51 Bn | 44.83 Bn | 1.29 Bn | 6.23 Bn |
| 6 | Dexcom | 29.00 Bn | 27.88 Bn | 750.30 Mn | 4.33 Bn |
| 7 | GE HealthCare Technologies | 28.78 Bn | 26.49 Bn | 1.98 Bn | 10.43 Bn |
| 8 | Smith & Nephew | 28.00 Bn | 27.42 Bn | - | 4.10 Bn |
| 9 | Koninklijke Philips | 24.26 Bn | 21.22 Bn | 2.01 Bn | 11.13 Bn |
| 10 | Cerus | 570.78 Mn | 490.35 Mn | 27.89 Mn | 175.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 175.34 Mn |
| Dec 31, 2025 | 174.38 Mn |
| Sep 30, 2025 | 167.13 Mn |
| Jun 30, 2025 | 168.53 Mn |
| Mar 31, 2025 | 161.52 Mn |
| Dec 31, 2024 | 152.02 Mn |
| Sep 30, 2024 | 140.61 Mn |
| Jun 30, 2024 | 135.03 Mn |
| Mar 31, 2024 | 138.17 Mn |
| Dec 31, 2023 | 144.44 Mn |
| Sep 30, 2023 | 150.94 Mn |
| Jun 30, 2023 | 150.94 Mn |
| Mar 31, 2023 | 162.22 Mn |
| Dec 31, 2022 | 170.14 Mn |
| Sep 30, 2022 | 164.73 Mn |
| Jun 30, 2022 | 164.67 Mn |
| Mar 31, 2022 | 172.81 Mn |
| Dec 31, 2021 | 187.10 Mn |
| Sep 30, 2021 | 178.05 Mn |
| Jun 30, 2021 | 185.59 Mn |